Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
211.20    3.60 (1.73%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £918.76m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Update

11 Mar 2019 07:00

RNS Number : 4235S
Kier Group PLC
11 March 2019
 

 

 

 11 March 2019

 

KIER GROUP PLC

 

UPDATE

 

Kier Group plc (the "Company" or "the Group") today provides an update on the net debt position stated in its trading statement of 22 January 2019 and the Broadmoor Hospital redevelopment project.

The Group has revised its net debt position as at 31 December 2018 to £180.5m (from c.£130m) and, accordingly, has re-calculated its average month-end net debt for the six months ended 31 December 2018 as being c.£430m (from c.£370m).

 

In the course of preparing its FY19 interim results and finalising the 31 December 2018 net debt position, the Company identified a number of adjustments (in aggregate: £10.3m), principally relating to the Group's hedging activities, and has revised the classification of the debt (in aggregate: £40.2m) associated with certain Developments assets held for resale at 31 December 2018. The Group originally consolidated this debt balance within assets held for resale on its balance sheet; following the re-classification, the debt has been included within the Group's net debt position.

 

Of the £40.2m net debt, £9.8m relates to assets which have been sold since 1 January 2019, £14.1m relates to sales which are subject to binding sale agreements and expected to complete by 30 April 2019 and the balance of £16.3m relates to assets which are either being marketed for sale by 30 June 2019 or are under offer.

 

The Group continues to forecast a net cash position at 30 June 2019 and remains focused on reducing its average month-end net debt.

 

The Board has reviewed the operational progress and cost recovery programme of the Broadmoor Hospital redevelopment project. The first phase of the project is expected to be handed over shortly and the remaining work on the project, which accounts for less than 10% of its value, will commence shortly thereafter. The Group has recently agreed a process with the client which is designed to reach agreement with respect to the Group's entitlement to the additional costs associated with the project's delay. Following its most recent review, the Board has concluded that a non-underlying provision of £25m will be included in the Group's FY19 interim results in respect of future recoveries from the client and other third parties.

 

Whilst the Board notes the current political and economic uncertainty in the UK, and the implications for third party investment, the Group remains on course to meet its underlying FY19 expectations, with the full-year results being weighted towards the second-half of the financial year, as expected.

 

As previously announced, the Company will release its FY19 interim results on 20 March 2019.

 

- ENDS -

For further information, please contact: 

Louise Turner-Smith, Kier investor relations 

+44 (0)7976 790 012

Kier press office 

+44 (0)1767 355 903

Richard Mountain/Nick Hasell, FTI Consulting 

+44(0)20 3727 1340

 

 

 

Continued ……..

A conference call with Phil Cox (Executive Chairman) and Bev Dew (Finance Director) for analysts and investors will be held at 08.00 GMT today. Dial-in details are as follows:

 

United Kingdom

Dial-in

Tollfree/Freephone

0800 279 4827

United Kingdom, Local

Dial-in

Local

+44 (0)330 336 9401

 

Participant Passcode:

974678

 

This announcement contains inside information for the purposes of EU Regulation 596/2014. The person responsible for making this announcement on behalf of the Company is Hugh Raven, General Counsel and Company Secretary.

 

 

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 and the section of the Company's rights issue prospectus dated 30 November 2018 entitled "Risk factors" for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDJBMATMBABMPL
Date   Source Headline
20th Sep 20184:49 pmRNSDirector/PDMR Shareholding
20th Sep 20187:00 amRNSFinal Results
19th Sep 20183:37 pmRNSHolding(s) in Company
24th Aug 20183:56 pmRNSHolding(s) in Company
21st Aug 20183:01 pmRNSHolding(s) in Company
21st Aug 201810:14 amRNSDirector/PDMR Shareholding
1st Aug 201811:06 amRNSTotal Voting Rights
1st Aug 20187:12 amRNSFuture Proofing Kier Programme - Board Changes
19th Jul 20183:36 pmRNSDirector/PDMR Shareholding
12th Jul 201810:02 amRNSHolding(s) in Company
10th Jul 20187:01 amRNSHighways England Areas 3 and 9 contract extensions
10th Jul 20187:00 amRNSTrading Statement
4th Jul 20189:40 amRNSHolding(s) in Company
2nd Jul 20184:04 pmRNSAdditional Listing
2nd Jul 201811:40 amRNSBlock listing Interim Review
2nd Jul 201811:21 amRNSTotal Voting Rights
29th Jun 20184:23 pmRNSDisposal of Wheldon Contracts and Services Limited
21st Jun 20184:48 pmRNSDirector/PDMR Shareholding
19th Jun 20185:05 pmRNSHolding(s) in Company
19th Jun 201810:19 amRNSDirector/PDMR Shareholding
12th Jun 201812:39 pmRNSDirector/PDMR Shareholding
12th Jun 201812:34 pmRNSDirector/PDMR Shareholding
12th Jun 20189:31 amRNSHolding(s) in Company
11th Jun 20182:40 pmRNSDirector/PDMR Shareholding
7th Jun 20187:00 amRNSKier JV with Homes England and Cross Keys Homes
1st Jun 201810:59 amRNSDirector/PDMR Shareholding
29th May 20189:49 amRNSHolding(s) in Company
25th May 20183:09 pmRNSHolding(s) in Company
22nd May 20182:47 pmRNSDirector/PDMR Shareholding
21st May 20184:42 pmRNSDirector/PDMR Shareholding
21st May 20184:07 pmRNSDirector/PDMR Shareholding
21st May 20183:38 pmRNSDirector/PDMR Shareholding
21st May 20181:54 pmRNSAdditional Listing
9th May 20183:45 pmRNSDirector/PDMR Shareholding
27th Apr 20183:05 pmRNSDirector/PDMR Shareholding
26th Apr 20183:18 pmRNSHolding(s) in Company
18th Apr 20185:06 pmRNSDirector/PDMR Shareholding
5th Apr 20182:35 pmRNSHolding(s) in Company
3rd Apr 201810:14 amRNSTotal Voting Rights
21st Mar 20185:38 pmRNSDirector/PDMR Shareholding
20th Mar 20185:09 pmRNSDirector/PDMR Shareholding
20th Mar 20182:16 pmRNSDirector/PDMR Shareholding
19th Mar 201812:41 pmRNSDirector/PDMR Shareholding
15th Mar 20183:13 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSHalf-year Report
9th Mar 201811:46 amRNSHolding(s) in Company
20th Feb 201811:03 amRNSDirector/PDMR Shareholding
5th Feb 201810:20 amRNSHolding(s) in Company
31st Jan 201811:06 amRNSHolding(s) in Company
29th Jan 201810:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.